Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.35B | 14.81B | 14.06B | 12.68B | 11.62B | Gross Profit |
8.53B | 8.08B | 7.32B | 6.98B | 6.49B | EBIT |
2.59B | 3.19B | 2.60B | 2.89B | 2.48B | EBITDA |
3.38B | 3.97B | 3.58B | 3.74B | 2.85B | Net Income Common Stockholders |
1.44B | 2.18B | 1.44B | 2.15B | 1.32B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
510.00M | 267.00M | 535.00M | 567.00M | 240.00M | Total Assets |
53.43B | 52.13B | 51.84B | 50.60B | 49.78B | Total Debt |
17.27B | 14.82B | 11.97B | 11.88B | 13.49B | Net Debt |
16.76B | 14.56B | 11.43B | 11.31B | 13.25B | Total Liabilities |
29.19B | 26.45B | 26.71B | 25.63B | 25.95B | Stockholders Equity |
24.24B | 25.68B | 25.13B | 24.97B | 23.83B |
Cash Flow | Free Cash Flow | |||
1.66B | 848.00M | 2.46B | 2.42B | 1.94B | Operating Cash Flow |
2.22B | 1.33B | 2.84B | 2.87B | 2.46B | Investing Cash Flow |
-1.61B | -784.00M | -1.14B | 210.00M | -316.00M | Financing Cash Flow |
-223.00M | -832.00M | -1.73B | -2.76B | -1.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $38.67B | 25.17 | 17.43% | 2.54% | 11.73% | -15.34% | |
77 Outperform | $201.05B | 21.09 | 52.42% | 3.70% | 0.42% | 5.77% | |
76 Outperform | $45.87B | 32.11 | 5.77% | 2.68% | 3.62% | -32.23% | |
76 Outperform | $55.55B | 38.47 | 21.27% | ― | 4.94% | -4.13% | |
74 Outperform | $11.39B | 20.78 | 44.38% | 0.46% | 3.69% | 60.51% | |
73 Outperform | $300.95B | 28.42 | 41.86% | 2.81% | 1.96% | -0.45% | |
62 Neutral | $20.22B | 13.99 | -16.14% | 3.22% | 1.15% | 3.41% |
On March 31, 2025, Keurig Dr Pepper Inc. entered into a new $4 billion unsecured revolving credit agreement with JPMorgan Chase Bank, which will mature on March 31, 2030. This agreement, replacing a previous one from February 2022, is intended for general corporate purposes and working capital, potentially enhancing the company’s financial flexibility and operational capacity.
On February 28, 2025, Keurig Dr Pepper Inc. experienced significant changes in its board of directors as three members affiliated with JAB BevCo B.V. resigned, reducing the board size from eleven to eight. This coincided with the completion of a public secondary offering by the Selling Stockholder, resulting in gross proceeds of approximately $2.7 billion, although the company did not receive any proceeds from this sale.
Andrew Archambault, President of U.S. Refreshment Beverages at Keurig Dr Pepper, has resigned effective January 13, 2025, and will assist in the transition until his departure on January 31, 2025. His resignation could potentially impact the company’s operations, as he is a named executive officer, but the company aims for a smooth transition to his successor.